首页|阿托伐他汀联合美托洛尔治疗CHF的效果及其治疗机制分析

阿托伐他汀联合美托洛尔治疗CHF的效果及其治疗机制分析

扫码查看
目的 探讨阿托伐他汀联合美托洛尔治疗慢性心力衰竭(CHF)患者的效果及作用机制.方法 80 例CHF患者随机分为两组各40例.对照组给予阿托伐他汀钙治疗,观察组在对照组基础上给予琥珀酸美托洛尔治疗.比较两组的治疗效果、血清指标以及不良反应.结果 观察组的总有效率为 95.00%,高于对照组的 70.00%(P<0.05).治疗后,观察组的NT-proBNP、CysC水平均低于对照组(P<0.05).两组的恶心呕吐、失眠、头晕头痛、腹泻、口干发生率比较,差异均无统计学意义(P>0.05).结论 阿托伐他汀联合美托洛尔治疗CHF的效果较好,安全性较高,其治疗机制可能与抑制NT-proBNP、CysC的表达有关.
Analysis on the Effect of Atorvastatin Combined with Metoprolol in the Treatment of CHF and Its Therapeutic Mechanism
Objective To explore the effect of atorvastatin combined with metoprolol in the treatment of chronic heart failure(CHF)and its therapeutic mechanism.Methods A total of 80 patients with CHF were randomly divided into two groups,with 40 cases in each group.The control group was treated with atorvastatin calcium,and the observation group was treated with metoprolol succinate on the basis of the control group.The therapeutic effect,serum indicators and adverse reactions were compared between the two groups.Results The total effective rate in the observation group was 95.00%,higher than 70.00%in the control group(P<0.05).After treatment,the levels of NT-proBNP and CysC in the observation group were lower than those in the control group(P<0.05).No significant difference was found in the incidences of nausea&vomiting,insomnia,dizziness&headache,diarrhea and dry mouth between the two groups(all P>0.05).Conclusions Atorvastatin combined with metoprolol has good effect and high safety in the treatment of CHF,and its therapeutic mechanism may be related to the inhibition of the expressions of NT-proBNP and CysC.

AtorvastatinMetoprololChronic heart failureTherapeutic mechanism

王广辉、魏新果

展开 >

河南省镇平县中医院心内科,河南南阳 474250

阿托伐他汀 美托洛尔 慢性心力衰竭 治疗机制

2024

临床医学工程
国家医疗保健器具工程技术研究中心

临床医学工程

影响因子:0.193
ISSN:1674-4659
年,卷(期):2024.31(2)
  • 9